Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Vital Therapies Company Profile (NYSE:VTL)

Consensus Ratings for Vital Therapies (NYSE:VTL) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $32.00 (41.28% upside)

Analysts' Ratings History for Vital Therapies (NYSE:VTL)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/25/2014Credit SuisseInitiated CoverageBuy$20.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
7/14/2014William BlairBoost Price Target$36.00ViewTweet This Rating  Share This Rating on StockTwits
5/12/2014Bank of AmericaInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
5/12/2014Canaccord GenuityInitiated CoverageBuy$20.00ViewTweet This Rating  Share This Rating on StockTwits
5/12/2014William BlairInitiated CoverageOutperform$28.00ViewTweet This Rating  Share This Rating on StockTwits
5/12/2014Credit SuisseInitiated CoverageOutperform$16.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 8/1/2012 forward)